Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Travera Inc
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Novartis
ViroMissile, Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
SAPU NANO (US) LLC
Fox Chase Cancer Center
AccSalus Biosciences, Inc.
Chongqing Precision Biotech Co., Ltd
Novelty Nobility, Inc.
Vyriad, Inc.
AC Camargo Cancer Center
National Cancer Institute (NCI)
Taproot Health
Travera Inc
23andMe, Inc.
Mayo Clinic
University Medical Center Groningen
University Medical Center Groningen
Hoffmann-La Roche
The Affiliated Hospital of Qingdao University
Institut Bergonié
Xencor, Inc.
The Affiliated Hospital of Qingdao University
The Affiliated Hospital of Qingdao University
EMD Serono
SpeciCare
AHS Cancer Control Alberta
Eli Lilly and Company
AbbVie
Emory University
University of Southern California
Stanford University
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Yale University
INSYS Therapeutics Inc
Exelixis
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Adherex Technologies, Inc.